Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | SRD5A2 | P31213 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28170706 | 0.98 | ALDH1A1 (0.59) | ALDH1A1KMT2ATP53TSHRSRD5A2 | |
| SCHEMBL8403545 | 0.85 | POLB (0.61) | ALDH1A1KMT2ATSHRPOLBGAA | |
| SCHEMBL7151365 | 0.84 | KMT2A (0.67) | ALDH1A1KMT2ASMN1; SMN2POLBMEN1 | |
| SCHEMBL10775090 | 0.84 | POLB (0.52) | ALDH1A1KMT2ASRD5A2SMN1; SMN2POLB | |
| SCHEMBL2401022 | 0.83 | ALDH1A1 (0.57) | ALDH1A1KMT2ATP53TSHRSRD5A2 | |
| SCHEMBL8161885 | 0.83 | POLB (0.47) | ALDH1A1KMT2APOLBL3MBTL1CA2 | |
| SCHEMBL8277240 | 0.81 | CA2 (0.62) | ALDH1A1KMT2ATSHRPOLBKDM4E | |
| SCHEMBL276932 | 0.81 | CA2 (0.62) | ALDH1A1KMT2ATP53TSHRSRD5A2 | |
| SCHEMBL16162416 | 0.81 | ALDH1A1 (0.56) | ALDH1A1KMT2ASRD5A2SMN1; SMN2MEN1 | |
| SCHEMBL28150711 | 0.81 | GRIN2D (0.56) | ALDH1A1KMT2ATP53SMN1; SMN2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250033082-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-30 | — | — | US | claimed |
| EP-4423178-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2024-09-04 | — | — | EP | claimed |
| CN-118201991-A | Methods and compositions for reducing solvent release from agrochemical formulations and reducing agrochemical formulation odor | 安道麦马克西姆有限公司 | 2024-06-14 | — | — | CN | claimed |
| WO-2023073536-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2023-05-04 | — | — | WO | claimed |
| CN-101891569-B | Preparation method of alpha-aromatic ketone compound | UNIV WUHAN | 2013-07-24 | — | — | CN | claimed |
| EP-2413973-A1 | POLYMERIC CONJUGATES OF PACLITAXEL AND DOCETAXEL WITH PH-CONTROLLED RELEASING OF THE CANCEROSTATIC AGENT | Zentiva, K.S. (CZ) | 2012-02-08 | — | — | EP | claimed |
| WO-2010091650-A1 | POLYMERIC CONJUGATES OF PACLITAXEL AND DOCETAXEL WITH PH-CONTROLLED RELEASING OF THE CANCEROSTATIC AGENT | ZENTIVA, K.S. (CZ) | 2010-08-19 | — | — | WO | claimed |
| US-20250033082-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-30 | — | — | US | disclosed |
| EP-4423178-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2024-09-04 | — | — | EP | disclosed |
| EP-4401795-A1 | FLUORESCENTLY LABELLED POLYMER FOR TUMOUR VISUALIZATION, METHOD OF ITS PREPARATION AND USE THEREOF | Ustav Makromolekularni Chemie AV CR, v.v.i. (CZ) | 2024-07-24 | — | — | EP | disclosed |
| CN-118201991-A | Methods and compositions for reducing solvent release from agrochemical formulations and reducing agrochemical formulation odor | 安道麦马克西姆有限公司 | 2024-06-14 | — | — | CN | disclosed |
| US-20230157999-A1 | PYRANO[4,3-B]INDOLE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) | VERTEX PHARMACEUTICALS (SAN DIEGO) LLC | 2023-05-25 | — | — | US | disclosed |
| WO-2023073536-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2023-05-04 | — | — | WO | disclosed |
| US-4753962-A | HYPOGLYCEMIC, ANTIOBESITY AGENT | BEECHAM GROUP P.L.C. (GB) | 1988-06-28 | — | — | US | disclosed |
| US-4654371-A | ANTI-OBESITY, HYPOGLYCEMIA AGENTS | BEECHAM GROUP P.L.C. (GB) | 1987-03-31 | — | — | US | disclosed |
| US-4530842-A | Containing a cyano substitution in position 3 | SANDOZ LTD. (CH) | 1985-07-23 | — | — | US | disclosed |
| US-4478849-A | HYPERGLYCEMIC AGENTS | BEECHAM GROUP LIMITED (GB) | 1984-10-23 | — | — | US | disclosed |
| WO-1983004024-A1 | 2(1H)-PYRIDONE DERIVATIVES, PREPARATION THEREOF AND COMPOSITION CONTAINING THEM | SANDOZ AG (CH) | 1983-11-24 | — | — | WO | disclosed |
| EP-0006735-B1 | SECONDARY AMINES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE | BEECHAM GROUP PLC (GB) | 1983-06-15 | — | — | EP | disclosed |
| EP-0006735-A1 | Secondary amines, their preparation, pharmaceutical compositions containing them and their use | BEECHAM GROUP PLC (GB) | 1980-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230157999-A1 | PYRANO[4,3-B]INDOLE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) | SERPINA2, SERPINB1, SERPINE1 | ALDH1A1 267/4885KMT2A 4356/4885TP53 2405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.